Skip to main content
European Commission logo print header

Disrupting Orthotics and Prosthetics Market with Open Digital Platform

Descrizione del progetto

Una piattaforma aperta facilita la progettazione di ortesi e protesi personalizzate stampate in 3D

Il mercato dei dispositivi ortesici e protesici su misura è in rapida crescita a causa dell’invecchiamento della popolazione e dell’aumento di patologie quali le malattie vascolari e il diabete. Entro il 2027, un dispositivo ortesico e protesico su tre sarà stampato in 3D. L’obiettivo del progetto OP-PLATFORM, finanziato dall’UE, è democratizzare la stampa 3D per tutti i medici specialisti. I ricercatori svilupperanno una piattaforma digitale rivoluzionaria che consentirà ai medici di progettare dispositivi di alta qualità specifici per il paziente e di ordinarli direttamente. Il team utilizzerà l’intelligenza artificiale, l’apprendimento automatico e algoritmi avanzati per automatizzare l’intero processo di progettazione.

Obiettivo

Custom-made orthotic and prosthetic (O&P) market grows rapidly as the global population ages and suffers from civilisation diseases. In the next 10 years the O&P industry will be disrupted by digital economy (automatisation, 3D printing and 3D scanning). Due to rising costs of O&P products and patients’ demand for improved comfort, function and aesthetics, every third O&P product will be 3D printed by 2027. However 3DP products need to be custom designed and that is costly, know-how & time demanding. With our proprietary technology and 25 years experience in the O&P market, Invent Medical set to become the Uber in orthotics and seize this market share with the Open Digital Platform by leveraging 3rd parties and automating & democratising the whole process in an ultra scalable and affordable way. We are offering benefits of digitalisation to medical facilities to improve people’s life worldwide as custom-made orthoses and prostheses are the only effective solution in a treatment of difficult injuries, deficiencies and civilisation diseases.
The goal of Phase 1 of the project is to assess the feasibility of the Open Digital Platform business model. Activities will be focused on advanced Market analysis, IP research, Licensing of products, a Business Plan preparation and Pilot tests. Pilot testing of the platform will be conducted on two product lines to verify viability of the platform and cooperation with 3rd parties providing sales & support, manufacturing and computing. The project will have an impact on the global market due to global availability of a new generation of 3DP O&P products. Our disruptive business model complies with the EU strategy in healthcare to promote good health and healthy ageing by developing innovative solutions.

Invito a presentare proposte

H2020-EIC-SMEInst-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-SMEInst-2018-2020-1

Meccanismo di finanziamento

SME-1 - SME instrument phase 1

Coordinatore

INVENT MEDICAL GROUP SRO
Contribution nette de l'UE
€ 50 000,00
Indirizzo
TECHNOLOGICKA 376/5
708 00 OSTRAVA
Cechia

Mostra sulla mappa

PMI

L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.

Regione
Česko Moravskoslezsko Moravskoslezský kraj
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
€ 71 429,00